Use of the New Solitaire™ AB Device for Mechanical Thrombectomy When Merci Clot Retriever Has Failed to Remove the Clot

Abstract

The Merci Retrieval System™ (Concentric Medical, Mountain View, CA, USA) was approved in 2004 for restoring blood flow in patients experiencing an acute stroke who are otherwise ineligible for intravenous tPA, or in whom intravenous tPA treatment has failed. However, this treatment results in successful recanalization in less than 60% of treatable vessels (Multi MERCI trial). We describe the use of a novel device, the Solitaire™ AB Neurovascular Remodeling Device (ev3 Inc., Irvine, CA, USA) that received the CE Mark for the treatment of neurovascular disease in 2007 and can recanalize arteries when MERCI has failed.

We describe a case of mechanical thrombectomy in which a new device, Solitaire™ AB, was used for acute cerebral ischemia in the setting of middle cerebral artery occlusion after unsuccessful recanalization with the MERCI® Retriever. Excellent angiographic and good clinical results were obtained without any complication.

The Solitaire™ AB device was able to retrieve and remove clots efficiently from the middle cerebral artery when the MERCI system failed, thereby offering a new alternative in the treatment of acute ischemic stroke.

Keywords

thrombectomy embolectomy reperfusion stroke acute interventional neuroradiology MERCI solitaire AB

Get full access to this article

View all access options for this article.

References

Martinez

Zoarski

: Mechanical thrombectomy of the internal carotid artery and middle cerebral arteries for acute stroke by using the retriever device. Am J Neuroradiol 25: 1812–1815, 2004.

Henkes

Flesser

: A novel microcatheter-delivered, highly-flexible and fully-retrievable stent, specifically designed for intracranial use. Interventional Neuroradiology 9: 391–393, 2003.

Smith WS, for the Multi MERCI Investigators: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi mechanical embolus removal in cerebral ischemia (MERCI) trial, Part I. Am J Neuroradiol 27: 1177–1182, 2006.

Henkes

Drepper

: Technical note on VDS. A system for the endovascular electrolytical detachment of platinum coils at variable length. Interventional Neuroradiology 8: 197–200, 2002.

Furlan

Higashida

: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282: 2003–2011, 1999.

Gobin

Starkman

: MERCI I: A phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 35: 2848–2854, 2004.

Smith

Sung

, for the MERCI Trial Investigators: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 36: 1432–1440, 2005.

Smith

Sung

: Mechanical thrombectomy for acute ischemic stroke final results of the multi MERCI trial. Stroke 39: 1205–1212, 2008.

Del Zoppo

Poeck

: Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86, 1992.

10.

The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 333: 1581–1587, 1995.

11.

Kelly

Turner

: Revascularization of symptomatic subacute cerebrovascular occlusions with a self-expanding intracranial stent system. Neurosurgery 64(1): 72–78, 2009.

12.

IMS trial investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 35: 904–911, 2004.